Sale by Timothy Shannon of 19275 shares of Arvinas
| ARVN Stock | USD 7.72 0.49 6.78% |
About 59% of all Arvinas' investors are looking to take a long position. The analysis of overall sentiment of trading Arvinas stock suggests that some investors are interested at this time. Arvinas' investing sentiment overview a quick insight into current market opportunities from investing in Arvinas. Many technical investors use Arvinas stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Filed transaction by Arvinas Inc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Cash Flow Correlation
Arvinas' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Arvinas' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Arvinas Fundamental Analysis
We analyze Arvinas' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arvinas using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arvinas based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Arvinas is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Arvinas Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arvinas stock to make a market-neutral strategy. Peer analysis of Arvinas could also be used in its relative valuation, which is a method of valuing Arvinas by comparing valuation metrics with similar companies.
Peers
Arvinas Related Equities
| CCCC | C4 Therapeutics | 6.75 | ||||
| BDTX | Black Diamond | 4.71 | ||||
| PLRX | Pliant Therapeutics | 4.32 | ||||
| KYMR | Kymera Therapeutics | 2.11 | ||||
| FHTX | Foghorn Therapeutics | 1.92 | ||||
| GLUE | Monte Rosa | 1.43 | ||||
| NRIX | Nurix Therapeutics | 0.99 | ||||
| RARE | Ultragenyx | 0.85 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.72 | ||||
| RVMD | Revolution Medicines | 0.20 | ||||
| IPSC | Century Therapeutics | 0 | ||||
| KURA | Kura Oncology | 0.31 | ||||
| STTK | Shattuck Labs | 0.40 | ||||
| RLAY | Relay Therapeutics | 1.22 | ||||
| STOK | Stoke Therapeutics | 2.43 |
Check out Arvinas Hype Analysis, Arvinas Correlation and Arvinas Performance. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share | Quarterly Revenue Growth 6.462 | Return On Assets | Return On Equity |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.